{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:54:48Z","timestamp":1772556888012,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clml.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T03:10:24Z","timestamp":1584673824000},"page":"e606-e615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Asmaa","family":"Mohsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Taalab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashawa","family":"Abousamra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5832-3561","authenticated-orcid":false,"given":"Mohamed","family":"Mabed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.03.007_bib1","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular Lymphoma International Prognostic Index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.03.007_bib2","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project","volume":"27","author":"Federico","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.03.007_bib3","article-title":"Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP","volume":"7","author":"Li","year":"2012","journal-title":"PLos One"},{"key":"10.1016\/j.clml.2020.03.007_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3324\/haematol.2013.088161","article-title":"Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era","volume":"99","author":"Tadmor","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.03.007_bib5","first-page":"45","article-title":"Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma","volume":"6","author":"Porrata","year":"2015","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.clml.2020.03.007_bib6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2001.19.3.720","article-title":"Cd4+ T-cell immune response to large B-cell non-Hodgkin\u2019s lymphoma predicts patient outcome","volume":"19","author":"Ansell","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.03.007_bib7","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.03.007_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V98.3.579","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma","volume":"98","author":"Porrata","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.03.007_bib9","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/annonc\/mdp531","article-title":"Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story","volume":"21","author":"Bari","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.03.007_bib10","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2011.112","article-title":"The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma","volume":"25","author":"Wilcox","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.03.007_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdq314","article-title":"Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"22","author":"Huang","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.03.007_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-8722-4-34","article-title":"Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy","volume":"4","author":"Kim","year":"2011","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.clml.2020.03.007_bib13","first-page":"947s","article-title":"Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma","volume":"7","author":"Dworacki","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2020.03.007_bib14","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas","volume":"69","author":"Ray-Coquard","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2020.03.007_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.clml.2020.03.007_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12915-017-0392-4","article-title":"Tissue macrophages: heterogeneity and functions","volume":"15","author":"Gordon","year":"2017","journal-title":"BMC Biol"},{"key":"10.1016\/j.clml.2020.03.007_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"1242","author":"Condeelis","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.clml.2020.03.007_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ijc.25969","article-title":"Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer\/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15","volume":"130","author":"Ishii","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clml.2020.03.007_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1634\/theoncologist.2012-0034","article-title":"The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin\u2019s lymphoma: correlation with tumor associated macrophages","volume":"17","author":"Koh","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2020.03.007_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ajh.23566","article-title":"The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy","volume":"88","author":"Rambaldi","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.03.007_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12185-014-1576-0","article-title":"Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma","volume":"99","author":"Kumagai","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2020.03.007_bib22","first-page":"861","article-title":"The prognostic significance of peripheral Blood ALC\/AMC in follicular lymphoma patients treated with R-CHOP-like chemotherapy","volume":"26","author":"Xu","year":"2016","journal-title":"China Oncol"},{"key":"10.1016\/j.clml.2020.03.007_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.clml.2014.10.001","article-title":"Peripheral blood lymphocyte\/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era","volume":"15","author":"Belotti","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2020.03.007_bib24","doi-asserted-by":"crossref","first-page":"31926","DOI":"10.18632\/oncotarget.7876","article-title":"Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis","volume":"7","author":"Gu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2020.03.007_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2011.050138","article-title":"Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in classical Hodgkin\u2019s lymphoma","volume":"97","author":"Porrata","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.03.007_bib26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2141.2006.06232.x","article-title":"Absolute lymphocyte count predicts overall survival in follicular lymphomas","volume":"134","author":"Siddiqui","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.03.007_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2007.06596.x","article-title":"Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas","volume":"137","author":"Behl","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.03.007_bib28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/10428190802226425","article-title":"Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma","volume":"49","author":"Cox","year":"2008","journal-title":"Leuk Lymphoma"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020301403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020301403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:10Z","timestamp":1761870850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020301403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2152265020301403"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.03.007","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}